JP2019516797A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019516797A5 JP2019516797A5 JP2019513481A JP2019513481A JP2019516797A5 JP 2019516797 A5 JP2019516797 A5 JP 2019516797A5 JP 2019513481 A JP2019513481 A JP 2019513481A JP 2019513481 A JP2019513481 A JP 2019513481A JP 2019516797 A5 JP2019516797 A5 JP 2019516797A5
- Authority
- JP
- Japan
- Prior art keywords
- throat
- composition according
- nasal congestion
- inflammation
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims description 23
- 150000001735 carboxylic acids Chemical class 0.000 claims description 18
- 150000003839 salts Chemical class 0.000 claims description 17
- 206010028735 Nasal congestion Diseases 0.000 claims description 15
- 208000036142 Viral infection Diseases 0.000 claims description 14
- 210000002345 respiratory system Anatomy 0.000 claims description 14
- 230000009385 viral infection Effects 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 13
- 206010061218 Inflammation Diseases 0.000 claims description 12
- 230000004054 inflammatory process Effects 0.000 claims description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 6
- 208000024891 symptom Diseases 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 3
- 235000019260 propionic acid Nutrition 0.000 claims description 3
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 230000000694 effects Effects 0.000 claims description 2
- 239000007937 lozenge Substances 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims 12
- 229940079593 drug Drugs 0.000 claims 11
- 230000002045 lasting effect Effects 0.000 claims 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 1
- 208000027157 chronic rhinosinusitis Diseases 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16169882.4 | 2016-05-17 | ||
| EP16169882 | 2016-05-17 | ||
| PCT/EP2017/061832 WO2017198702A1 (en) | 2016-05-17 | 2017-05-17 | Carboxylic acid for treating/preventing nasal congestion |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019516797A JP2019516797A (ja) | 2019-06-20 |
| JP2019516797A5 true JP2019516797A5 (enExample) | 2020-06-18 |
| JP6975473B2 JP6975473B2 (ja) | 2021-12-01 |
Family
ID=56014856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019513481A Active JP6975473B2 (ja) | 2016-05-17 | 2017-05-17 | 鼻詰まりを治療／予防するためのカルボン酸 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20200000751A1 (enExample) |
| EP (1) | EP3458043A1 (enExample) |
| JP (1) | JP6975473B2 (enExample) |
| KR (1) | KR102430892B1 (enExample) |
| CN (1) | CN109152754A (enExample) |
| AU (1) | AU2017266726A1 (enExample) |
| BR (1) | BR112018072177A2 (enExample) |
| CA (1) | CA3020485A1 (enExample) |
| CL (1) | CL2018003270A1 (enExample) |
| MX (1) | MX2018013475A (enExample) |
| RU (1) | RU2018143564A (enExample) |
| SG (2) | SG10202006016QA (enExample) |
| WO (1) | WO2017198702A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11206245B2 (en) * | 2009-10-14 | 2021-12-21 | Trice Imaging, Inc. | Systems and devices for encrypting, converting and interacting with medical images |
| US11948678B2 (en) * | 2009-10-14 | 2024-04-02 | Trice Imaging, Inc. | Systems and devices for encrypting, converting and interacting with medical images |
| GB202004690D0 (en) * | 2020-03-31 | 2020-05-13 | Edinburgh Napier Univ | Composition for enhancing immune response of cells |
| US12414928B2 (en) | 2021-05-14 | 2025-09-16 | Rene Dumalaog Javier | Viral inactivation spray and gargling formulation |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6063363A (en) * | 1997-05-27 | 2000-05-16 | Goodwin; Gary J | Treatment for upper respiratory tract infections with potassium salts |
| CZ301349B6 (cs) * | 1997-12-23 | 2010-01-27 | Schering Corporation | Prostredek k lécbe respiracních a kožních onemocnení, který obsahuje alespon jednoho antagonistu leukotrienu a alespon jedno antihistaminikum |
| US8912174B2 (en) * | 2003-04-16 | 2014-12-16 | Mylan Pharmaceuticals Inc. | Formulations and methods for treating rhinosinusitis |
| DE10337186A1 (de) * | 2003-08-13 | 2005-03-17 | Merck Patent Gmbh | Wässrige Wirkstoff-Lösung |
| EP1671629A4 (en) * | 2003-09-19 | 2008-11-26 | Otsuka Pharma Co Ltd | HUMAN BETA DEFENSIN SECRETION AMPLIFIER |
| US20070256812A1 (en) * | 2006-04-19 | 2007-11-08 | Wen-Chen Wei | Multidirectional heat dissipating structure |
| US20070286812A1 (en) * | 2006-06-09 | 2007-12-13 | Toutounghi Camille | Nasal formulation |
| CA2886270C (en) * | 2012-10-03 | 2020-04-07 | Proponent Biotech Gmbh | Esters of short chains fatty acids for use in the treatment of immunogenic disorders |
-
2017
- 2017-05-17 CA CA3020485A patent/CA3020485A1/en not_active Abandoned
- 2017-05-17 EP EP17723139.6A patent/EP3458043A1/en not_active Withdrawn
- 2017-05-17 WO PCT/EP2017/061832 patent/WO2017198702A1/en not_active Ceased
- 2017-05-17 CN CN201780029992.2A patent/CN109152754A/zh active Pending
- 2017-05-17 JP JP2019513481A patent/JP6975473B2/ja active Active
- 2017-05-17 US US16/097,784 patent/US20200000751A1/en not_active Abandoned
- 2017-05-17 KR KR1020187033155A patent/KR102430892B1/ko active Active
- 2017-05-17 RU RU2018143564A patent/RU2018143564A/ru unknown
- 2017-05-17 MX MX2018013475A patent/MX2018013475A/es unknown
- 2017-05-17 SG SG10202006016QA patent/SG10202006016QA/en unknown
- 2017-05-17 SG SG11201808322PA patent/SG11201808322PA/en unknown
- 2017-05-17 BR BR112018072177-8A patent/BR112018072177A2/pt not_active IP Right Cessation
- 2017-05-17 AU AU2017266726A patent/AU2017266726A1/en not_active Abandoned
-
2018
- 2018-11-16 CL CL2018003270A patent/CL2018003270A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5643849B2 (ja) | スプレー用ゲルタイプ皮膚・粘膜付着型製剤およびそれを用いた投与システム | |
| US8758816B2 (en) | Compositions comprising azelastine and methods of use thereof | |
| JP6762931B2 (ja) | 経鼻組成物と該経鼻組成物の使用方法の改善 | |
| RU2019100425A (ru) | Новая доза и препаративная форма | |
| US20070020330A1 (en) | Compositions comprising azelastine and methods of use thereof | |
| CN1222287C (zh) | 含有佐米曲普坦的药用制剂 | |
| US9861647B2 (en) | Calcium glycerophosphate for treating and preventing respiratory diseases or conditions | |
| JP2019516797A5 (enExample) | ||
| CA2724277A1 (en) | Recombinant human cc10 and compositions thereof for use in the treatment of nasal rhinitis | |
| RU2018143564A (ru) | Карбоновая кислота, предназначенная для лечения/предупреждения заложенности носа | |
| JP6770091B2 (ja) | ニコチン性アセチルコリン受容体アゴニストによる副鼻腔粘膜疾患を処置するための組成物及び方法 | |
| JP2016505050A5 (enExample) | ||
| JP7369523B2 (ja) | 中等度～重度のインフルエンザの処置 | |
| CA2701388C (en) | Calcium glycerophosphate for treating and preventing respiratory diseases or conditions | |
| US11819508B2 (en) | Miltefosine for the treatment of viral infections including covid-19 | |
| WO2023144614A1 (en) | Nasal compositions and methods thereof | |
| CN100496492C (zh) | 治疗慢性鼻窦炎的甲苯咪唑新剂型 | |
| RU2781144C2 (ru) | Усовершенствование назальных композиций и способ их использования | |
| HK1211463B (zh) | 喷雾用凝胶型皮肤．粘膜附着型制剂及使用它的给药系统 | |
| EA048350B1 (ru) | Применение даларгина для профилактики орви и предотвращения развития осложнений при заболеваниях орви | |
| JP2007022971A (ja) | 経鼻投与のための組成物 | |
| UA83852U (uk) | Фармацевтична композиція для виготовлення лікарських засобів, призначених для лікування захворювань носоглотки |